Financial Information
We lead the synthetic biology industry, having developed and successfully commercialized the most Lab-to-Market™ ingredients. Our sustainable ingredients are used in thousands of top global brands, including our own family of consumer brands in Clean Beauty and Health markets.
The following stock information comes from NASDAQ. Data and charts may be delayed by 15 minutes or more.
NASDAQAMRS
| Beta | 1.15 |
|---|---|
| Shares Outstanding | 369.4M |
| Average Volume (10 days) | 5.2M |
| Qtrly Dividend (Ann. Yield) | -- (--) |
Analyst Views
| Current Mean Recommendation | Hold |
|---|
| Strong Buy | 2 | |
|---|---|---|
| Buy | 0 | |
| Hold | 5 | |
| Underperform | 0 | |
| Sell | 1 |
Recent Insider Transactions
Alvarez Eduardo Chief Operating Officer | (231,368) Sell Apr 5, 2023 |
|---|---|
Eduardo Alvarez CHIEF OPERATING OFFICER | (231,368) Sell Apr 5, 2023 |
Geoffrey Duyk Director | 2,437 Dispose Jan 3, 2023 |
Geoffrey Duyk Director | 2,437 Acquire Jan 3, 2023 |
Elizabeth Dreyer CHIEF ACCOUNTING OFFICER | 125,000 Acquire Oct 17, 2022 |
MAKE GOOD.
NO COMPROMISE.®
